Widespread Access to Merck’s Molnupiravir in Philippines Even Though Drug Isn’t Authorized on Emergency Basis nor Approved

Widespread Access to Merck’s Molnupiravir in Philippines Even Though Drug Isn’t Authorized on Emergency Basis nor Approved

While a Phase 3 clinical trial investigating Merck’s molnupiravir in the Philippines seeks patients this isn’t a surprise given the imminent accessibility the drug now has to the local patient market. Currently allowed for compassionate use at several Philippines...

read more
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

By Di Pierro F, et al. Published June 24, 2021 in the International Journal of General Medicine Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential...

read more